In future research, AML development mechanism should be investigated based on the specific regulatory methods of lncRNA GAS5 for the transcriptional activity of IGF1R promoter from multiple perspectives to provide some ideas and experimental support for the rehabilitation of AML patients. The gene discussed is IGF1R; the disease is acute myeloid leukemia.